Contents 1. Executive Summary 2. Global AI in Medical Diagnostics Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Global AI in Medical Diagnostics Market Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Global AI in Medical Diagnostics Market 11.1. Market Size & forecast, 2020A-2030F 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12. Global AI in Medical Diagnostics Market: Market Segmentation 12.1. By Regions 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2. By Component: Market Share (2020-2030F) 12.2.1. Software, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.2. Service, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3. By Application: Market Share (2020-2030F) 12.3.1. In Vivo Diagnostics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3.2. In-Vitro Diagnostics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4. By End-User: Market Share (2020-2030F) 12.4.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.2. Diagnostic imaging centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.3. Diagnostic Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 13. Company Profile 13.1. Microsoft Corporation 13.1.1. Company Overview 13.1.2. Company Total Revenue (Financials) 13.1.3. Market Potential 13.1.4. Global Presence 13.1.5. Key Performance Indicators 13.1.6. SWOT Analysis 13.1.7. Product Launch 13.2. NVIDIA 13.3. IBM 13.4. Intel 13.5. Siemens Healthineers 13.6. GE Healthcare 13.7. Digital Diagnostics 13.8. Xilinx 13.9. InformAI 13.10. Enlitic 13.11. Day Zero Diagnostics 13.12. Aidence 13.13. Butterfly Network, Inc. 13.14. Prognos 13.15. Zebra Medical Vision Consultant Recommendation **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.